These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9340574)

  • 21. Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease.
    Moore M
    J Insur Med; 1998; 30(2):111-2. PubMed ID: 10339292
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
    Feeman WE
    Circulation; 2003 May; 107(20):e199. PubMed ID: 12777330
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypertension and clusters of risk factors in different stroke subtypes (an analysis of Hungarian patients via Budapest Stroke Data Bank).
    Aszalós Z; Barsi P; Vitrai J; Nagy Z
    J Hum Hypertens; 2002 Jul; 16(7):495-500. PubMed ID: 12080434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary heart disease risk factors among blood donors in northwest Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    East Afr Med J; 1998 Sep; 75(9):495-500. PubMed ID: 10493048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial predisposition to ischemic cardiopathy: role of homocysteine and genetic polymorphism of methylenetetrahydrofolate reductase].
    Potena L; Grigioni F; Mantovani V; Magnani G; Magelli C; Branzi A
    Ital Heart J Suppl; 2001 Jul; 2(7):748-53. PubMed ID: 11508292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulation of apolipoprotein expression].
    Chernyshov VA; Tseluĭko VI
    Tsitol Genet; 1991; 25(5):65-76. PubMed ID: 1686687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic studies in familial hyperlipoproteinemia, and therapeutic implications].
    de Gennes JL
    Ann Biol Clin (Paris); 1988; 46(1):1-3. PubMed ID: 3389574
    [No Abstract]   [Full Text] [Related]  

  • 29. Apolipoprotein E polymorphism, age and coronary heart disease.
    Kolovou GD; Anagnostopoulou KK
    Ageing Res Rev; 2007 Aug; 6(2):94-108. PubMed ID: 17224309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comments on Brønnum-Hansen: predicting the effect of prevention of ischaemic heart disease.
    Andersen LB; Saltin B
    Scand J Public Health; 2002; 30(4):315-6; author reply 317-8. PubMed ID: 12680510
    [No Abstract]   [Full Text] [Related]  

  • 31. [Genetically determined reduction in antioxidative protection and increased risk of ischemic heart disease--secondary publication].
    Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen HH; Jensen GB; Nordestgaard BG
    Ugeskr Laeger; 2005 Feb; 167(7):767-70. PubMed ID: 15779264
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercholesterolemia: genetic, dietary, and pharmacologic interrelationships.
    Levy RI
    Prog Clin Biol Res; 1981; 67():351-60. PubMed ID: 7029563
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Schaefer JR; Herzum M; Maisch B
    N Engl J Med; 1998 Nov; 339(22):1641-2. PubMed ID: 9867530
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiovascular risk among patients of general practices, who are not in current acute care].
    Jancsó Z; Márton H; Simay A; Ujhelyi I; Ilyés I
    Orv Hetil; 2003 Jul; 144(29):1433-9. PubMed ID: 12939864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E genotype in patients with cerebrovascular diseases and its effect on the disease outcome.
    Tamam Y; Tasdemir N; Toprak R; Tamam B; Iltumur K
    Int J Neurosci; 2009; 119(7):919-35. PubMed ID: 19466630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic metabolic defects in adults].
    Schwandt P; Richter WO
    Internist (Berl); 1989 Sep; 30(9):547-55. PubMed ID: 2681039
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
    Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymorphism of the angiotensin-converting enzyme gene in patients with coronary heart disease from Moscow population].
    Shadrina MI; Slominskiĭ PA; Miloserdova OV; Perova NV; Limborskaia SA
    Genetika; 2001 Apr; 37(4):540-4. PubMed ID: 11421129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The importance of apolipoproteins in dyslipidemias].
    Quintão EC
    Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.